Eli Lilly (LLY) FY2016 results: revenue $18.3 billion, down 8.2% on the year
Eli Lilly & Co. (LLY) reported revenue of $18.3 billion for fiscal 2016, the year ended 31 December 2016, down 8.2% on the year before. Net income was $2.7 billion, up 13.7%, and diluted earnings per share $2.58. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2017.
Revenue
$18.3 billion
-8.2% on the year
FY2009FY2016
Operating margin
n/a
FY2009FY2016
Net income
$2.7 billion
+13.7% on the year
FY2009FY2016
Diluted EPS
$2.58
+14.2% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
18,313
19,959
19,616
-8.2%
Cost of revenue
4,160
5,037
4,932
-17.4%
Gross profit
14,152
14,922
14,683
-5.2%
Gross margin
77.3%
74.8%
74.9%
Research and development
5,040
4,796
4,734
+5.1%
Selling, general and administrative
5,842
6,533
6,621
-10.6%
Interest expense
185
161
149
+14.9%
Pre-tax income
3,276
2,790
3,000
+17.4%
Income tax
551
382
610
+44.5%
Effective tax rate
16.8%
13.7%
20.3%
Net income
2,738
2,408
2,390
+13.7%
Net margin
14.9%
12.1%
12.2%
Diluted EPS
$2.58
$2.26
$2.23
+14.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
4,851
2,965
4,458
+63.6%
Capital expenditure
1,037
1,066
1,163
-2.7%
Free cash flow
3,814
1,898
3,296
+100.9%
Free cash flow margin
20.8%
9.5%
16.8%
Cash from investing
-3,139
26.8
-3,909
Cash from financing
-560
-3,111
-166
Depreciation and amortisation
1,497
1,428
1,379
+4.8%
Share-based compensation
255
218
156
+17.2%
Buybacks
600
750
800
-19.9%
Dividends paid
2,158
2,127
2,101
+1.5%
Dividend per share
$2.05
n/a
n/a
Diluted shares, weighted
1,062m
1,066m
1,074m
-0.4%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
14,008
14,571
15,373
-3.9%
Non-controlling interest
72.8
19.0
14.9
+283.2%
Debt
10,305
7,978
8,022
+29.2%
Other liabilities
14,420
13,000
12,898
+10.9%
Total liabilities and equity
38,806
35,569
36,308
+9.1%
Fixed assets
8,253
8,054
7,964
+2.5%
Goodwill
3,973
4,040
1,758
-1.7%
Intangible assets
4,358
5,035
2,884
-13.4%
Investments
6,664
4,432
5,524
+50.4%
Cash and equivalents
4,582
3,666
3,872
+25.0%
Receivables
4,029
3,513
3,235
+14.7%
Inventory
3,562
3,446
2,740
+3.4%
Other assets
3,385
3,384
8,331
+0.1%
Total assets
38,806
35,569
36,308
+9.1%
10-K for the year ended 31 December 2016, filed 21 February 2017: the filing.